• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动卒中患者抗凝治疗起始的最佳时机:一项系统评价

Optimal Timing of Anticoagulation Initiation in Stroke Patients With Atrial Fibrillation: A Systematic Review.

作者信息

Tariq Shaima Yasmeen, Ahmad Ali Raza

机构信息

Cardiology, Sahiwal Teaching Hospital, Sahiwal, PAK.

Hematology and Oncology, Hameed Latif Hospital Lahore, Lahore, PAK.

出版信息

Cureus. 2025 Jul 19;17(7):e88296. doi: 10.7759/cureus.88296. eCollection 2025 Jul.

DOI:10.7759/cureus.88296
PMID:40831845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12360109/
Abstract

This systematic review evaluates the optimal timing of anticoagulation in atrial fibrillation patients with acute ischemic stroke or transient ischemic attack. A comprehensive search across PubMed (94 records), Web of Science (121 records), Scopus (156 records), and the Cochrane Library (83 records) yielded 454 records. After screening 324 records and assessing 44 full texts, 13 studies were included: five randomized controlled trials and eight cohort studies, excluding those without comparisons of early versus delayed anticoagulation. The review analyzes studies comparing early and delayed initiation of oral anticoagulants (primarily direct oral anticoagulants (DOACs) and warfarin), focusing on outcomes such as recurrent ischemic stroke, symptomatic intracranial hemorrhage (sICH), and composite endpoints including recurrent stroke, sICH, systemic embolism, or mortality. Findings suggest that early anticoagulation, especially with DOACs, is safe and may reduce recurrent events without increasing the risk of sICH, particularly in cases with mild to moderate severity. However, varying definitions of timing, study designs, and limited data on severe strokes or in low-resource settings highlight research gaps. Future studies should investigate long-term outcomes and diverse populations to refine guidelines, particularly in resource-constrained environments.

摘要

本系统评价评估了急性缺血性卒中或短暂性脑缺血发作的房颤患者抗凝治疗的最佳时机。通过全面检索PubMed(94条记录)、Web of Science(121条记录)、Scopus(156条记录)和Cochrane图书馆(83条记录),共获得454条记录。在筛选324条记录并评估44篇全文后,纳入了13项研究:5项随机对照试验和8项队列研究,排除了未比较早期与延迟抗凝的研究。该评价分析了比较口服抗凝剂(主要是直接口服抗凝剂(DOACs)和华法林)早期与延迟起始治疗的研究,重点关注复发性缺血性卒中、症状性颅内出血(sICH)以及包括复发性卒中、sICH、全身性栓塞或死亡在内的复合终点等结局。研究结果表明,早期抗凝,尤其是使用DOACs,是安全的,并且可能在不增加sICH风险的情况下减少复发性事件,特别是在轻度至中度严重程度的病例中。然而,时间定义的差异、研究设计以及关于严重卒中或低资源环境下的数据有限,凸显了研究空白。未来的研究应调查长期结局并纳入不同人群,以完善指南,特别是在资源受限的环境中。

相似文献

1
Optimal Timing of Anticoagulation Initiation in Stroke Patients With Atrial Fibrillation: A Systematic Review.心房颤动卒中患者抗凝治疗起始的最佳时机:一项系统评价
Cureus. 2025 Jul 19;17(7):e88296. doi: 10.7759/cureus.88296. eCollection 2025 Jul.
2
Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.合并抗凝和抗血小板治疗用于伴有房颤的高危患者:一项系统评价。
Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300.
3
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial.急性缺血性卒中合并心房颤动后抗凝治疗的最佳时机(OPTIMAS):一项随机对照试验的统计分析计划
Trials. 2025 Feb 19;26(1):58. doi: 10.1186/s13063-025-08761-6.
4
Early vs Late Anticoagulation After Ischemic Stroke in Patients With Atrial Fibrillation and Covert Brain Infarcts.心房颤动合并隐匿性脑梗死患者缺血性卒中后早期与晚期抗凝治疗对比
Neurology. 2025 Jan 14;104(1):e210157. doi: 10.1212/WNL.0000000000210157. Epub 2024 Dec 19.
5
Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion.心脏节律管理设备植入时的间断抗凝与持续抗凝
Cochrane Database Syst Rev. 2025 Jan 28;1(1):CD013816. doi: 10.1002/14651858.CD013816.pub2.
6
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.癌症患者静脉血栓栓塞症长期治疗的抗凝治疗
Cochrane Database Syst Rev. 2018 Jun 19;6(6):CD006650. doi: 10.1002/14651858.CD006650.pub5.
7
Early versus delayed direct oral anticoagulant initiation in nonvalvular atrial fibrillation-associated acute ischemic stroke: A systematic review and meta-analysis.非瓣膜性心房颤动相关急性缺血性卒中中直接口服抗凝剂早期启动与延迟启动的系统评价和荟萃分析
J Stroke Cerebrovasc Dis. 2025 Aug;34(8):108371. doi: 10.1016/j.jstrokecerebrovasdis.2025.108371. Epub 2025 Jun 5.
8
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.直接口服抗凝剂与华法林在预防慢性肾脏病房颤患者中风和全身性栓塞事件方面的比较
Cochrane Database Syst Rev. 2017 Nov 6;11(11):CD011373. doi: 10.1002/14651858.CD011373.pub2.
9
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial.根据慢性肾脏病确定急性房颤卒中的抗凝时机:OPTIMAS试验
Stroke. 2025 Aug;56(8):1970-1979. doi: 10.1161/STROKEAHA.125.051457. Epub 2025 May 22.
10
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.心律失常成人患者行导管消融术时,中断与不中断抗凝治疗的比较。
Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD013504. doi: 10.1002/14651858.CD013504.pub2.

本文引用的文献

1
The Current Situation of Neurological Health in Bangladesh: A Perspective.孟加拉国神经系统健康现状:一种视角
Health Sci Rep. 2025 Mar 2;8(3):e70530. doi: 10.1002/hsr2.70530. eCollection 2025 Mar.
2
Understanding healthcare providers' perspectives on barriers to accessing stroke care at a resource-limited hospital in East Africa: A qualitative study from Mnazi Mmoja Referral Hospital in Zanzibar.了解东非一家资源有限医院的医疗服务提供者对获得中风护理障碍的看法:来自桑给巴尔Mnazi Mmoja转诊医院的定性研究。
PLOS Glob Public Health. 2025 Feb 24;5(2):e0004278. doi: 10.1371/journal.pgph.0004278. eCollection 2025.
3
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
急性缺血性卒中合并心房颤动后抗凝治疗的最佳时机(OPTIMAS):一项多中心、盲终点、4期随机对照试验。
Lancet. 2024 Oct 23. doi: 10.1016/S0140-6736(24)02197-4.
4
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.小、中、大面积缺血性脑卒中合并心房颤动患者的早期与晚期抗凝治疗:ELAN 随机临床试验的事后分析。
JAMA Neurol. 2024 Jul 1;81(7):693-702. doi: 10.1001/jamaneurol.2024.1450.
5
Optimal Timing for Resumption of Anticoagulation After Intracranial Hemorrhage in Patients With Mechanical Heart Valves.机械心脏瓣膜患者颅内出血后抗凝恢复的最佳时机。
J Am Heart Assoc. 2024 May 21;13(10):e032094. doi: 10.1161/JAHA.123.032094. Epub 2024 May 18.
6
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis.急性缺血性脑卒中后房颤患者口服抗凝剂起始时机:系统评价和荟萃分析。
Eur Stroke J. 2024 Dec;9(4):885-895. doi: 10.1177/23969873241251931. Epub 2024 May 14.
7
Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding.临床指南:严重危及生命出血患者的直接口服抗凝剂逆转。
Eur J Anaesthesiol. 2024 May 1;41(5):327-350. doi: 10.1097/EJA.0000000000001968. Epub 2024 Apr 4.
8
Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship.心房颤动与冠状动脉疾病:一项聚焦于这种关系治疗意义的综合综述。
World J Cardiol. 2023 May 26;15(5):229-243. doi: 10.4330/wjc.v15.i5.229.
9
The rising global burden of stroke.全球中风负担不断上升。
EClinicalMedicine. 2023 May 23;59:102028. doi: 10.1016/j.eclinm.2023.102028. eCollection 2023 May.
10
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.早期与晚期抗凝治疗房颤相关性脑卒中。
N Engl J Med. 2023 Jun 29;388(26):2411-2421. doi: 10.1056/NEJMoa2303048. Epub 2023 May 24.